PASSERON; Thierry

Patent Applications and Registrations

Patent applications and USPTO patent grants for PASSERON; Thierry.The latest application filed is for "proteins of the wnt signaling pathway and uses thereof in the diagnostic and treatment of hypopigmentation disorders".

Company Profile

6.7.13

PASSERON; Thierry - Nice FR
PASSERON; Thierry - Nice Cedex 3 FR
Passeron; Thierry - Batiment N/A FR
Passeron; Thierry - Rockville MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Proteins Of The Wnt Signaling Pathway And Uses Thereof In The Diagnostic And Treatment Of Hypopigmentation Disorders App 20210190800 - PASSERON; Thierry ; et al.	2021-06-24
Proteins of the WNT signaling pathway and uses thereof in the diagnostic and treatment of hypopigmentation disorders Grant 10,983,134 - Passeron , et al. April 20, 2	2021-04-20
Methods And Compositions For Treating Hyperpigmentation Disorders App 20210079100 - PASSERON; Thierry ; et al.	2021-03-18
Methods And Compositions For Treating Vitiligo App 20210061917 - PASSERON; Thierry ; et al.	2021-03-04
Substituted Halo-quinoline Derivates For Use In The Treatment Of Lymphomas And Leukemia App 20200360365 - PASSERON; Thierry ; et al.	2020-11-19
Substituted Halo-quinoline Derivatives, Method Of Preparation And Applications Thereof App 20200361872 - PASSERON; Thierry ; et al.	2020-11-19
4-anilino-quinoline Compounds As Anti-cancer Agents App 20200181089 - PASSERON; Thierry ; et al.	2020-06-11
GSK3B and uses thereof in the diagnostic and treatment of hypopigmentation disorders Grant 10,632,117 - Passeron , et al.	2020-04-28
Gsk3b And Uses Thereof In The Diagnostic And Treatment Of Hypopigmentation Disorders App 20190175594 - PASSERON; Thierry ; et al.	2019-06-13
Compositions and Methods for Inducing Senescence in Cancer Cells App 20180251763 - Passeron; Thierry ; et al.	2018-09-06
Proteins Of The Wnt Signaling Pathway And Uses Thereof In The Diagnostic And Treatment Of Hypopigmentation Disorders App 20180180631 - PASSERON; Thierry ; et al.	2018-06-28
Compositions and Methods for Inducing Senescence in Cancer Cells App 20160208249 - Passeron; Thierry ; et al.	2016-07-21
Compositions and methods for treating pigmentary conditions and melanoma Grant 8,946,291 - Hearing , et al. February 3, 2	2015-02-03
Treatment of skin conditions by Dickkopf1 (DKK1) Grant 8,476,236 - Hearing , et al. July 2, 2	2013-07-02
Treatment Of Skin Conditions By Dickkopf1 (dkk1) App 20120252735 - Hearing; Vincent ; et al.	2012-10-04
Regulation of skin characteristics by DICKKOPF1 (DKK1) Grant 8,198,244 - Hearing , et al. June 12, 2	2012-06-12
Compositions and Methods for Treating Pigmentary Conditions and Melanoma App 20110269691 - Hearing; Vincent J. ; et al.	2011-11-03
Regulation Of Skin Characteristics By Dickkopf1 (dkk1) App 20100317590 - Hearing; Vincent ; et al.	2010-12-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.